Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
Holding BEAM?
Track your performance easily

Beam Therapeutics (BEAM) Balance Sheet

1,237 Followers

Beam Therapeutics Balance Sheet

Beam Therapeutics's total assets for Q2 2024 were $1.26B, a decrease of -7.25% from the previous quarter. BEAM total liabilities were $407.17M for the fiscal quarter, a -8.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.46B$ 1.34B$ 1.47B$ 451.68M$ 156.10M
Total Liabilities
$ 478.38M$ 608.24M$ 647.72M$ 206.12M$ 55.15M
Total Equity Gross Minority
$ 971.22M$ 690.84M$ 826.74M$ 245.56M$ 100.94M
Total Capitalization
$ 1.14B$ 733.47M$ 826.74M$ 250.85M$ 105.36M
Preferred Stock Equity
----$ 302.05M
Capital Lease Obligations
---$ 100.23M$ 25.52M
Currency in USD

Beam Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis